Through signaling pathways such as Janus kinase/signal transducer and activator of transcription and nuclear factor kappa-light-chain-enhancer of activated B cells, MIG mediates responses to various cytokines, thereby influencing the tumor microenvironment [41]. The gene discussed is CXCL9; the disease is neoplasm.